Markers assessed | N patients assessed | % with at least 1 elevated marker | |||
---|---|---|---|---|---|
CEA | CA 15-3 | CYFRA 21-1 | CTC | ||
2 markers combinations | |||||
X | X | 239 | 72% | ||
X | X | 240 | 75% | ||
X | X | 257 | 75% | ||
X | X | 225 | 77% | ||
X | X | 206 | 80% | ||
X | X | 231 | 86% | ||
3 markers combinations | |||||
X | X | X | 251 | 83% | |
X | X | X | 233 | 86% | |
X | X | X | 234 | 88% | |
X | X | X | 234 | 88% | |
4 markers combination | |||||
X | X | X | X | 246 | 90% |